BPA Call 36C25723A0027-36C25726N0254
- Mdxhealth, Inc. received a $15,964.65 firm fixed price contract award from the Department of Veterans Affairs' Veterans Integrated Service Network 17 on June 5, 2025. This BPA call is for Genomic Prostate Score (GPS) testing services, a molecular diagnostic test designed to assess prostate cancer risk and guide personalized treatment decisions for veterans. The contract carries no set-aside designation and represents a delivery order against Mdxhealth's existing $240,000 blanket purchase...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded Mdxhealth, Inc. a $27,657.57 firm fixed-price blanket purchase agreement call for DX Prostate Testing services. The award, issued on April 3, 2025, with an ultimate completion date of April 2, 2026, represents a delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Mdxhealth, a for-profit molecular diagnostic company headquartered in Irvine,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a $27,657.57 firm fixed-price Blanket Purchase Agreement (BPA) call to Mdxhealth, Inc. for DX Prostate Testing services. The contract, which was awarded on April 3, 2026 with an ultimate completion date of April 2, 2027, is performed at the awardee's facility in Amarillo, Texas. This BPA call is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal...
- Mdxhealth, Inc. has been awarded a $1.22M delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for Oncotype DX GPS (Genomic Prostate Score) testing services. This firm fixed-price contract, effective through January 31, 2030, represents a call order against Mdxhealth's existing Blanket Purchase Agreement under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The work will be performed in Mather,...
- Mdxhealth, Inc. was awarded a $9,578.79 firm fixed price call under a Blanket Purchase Agreement with Veterans Integrated Service Network 17 (VISN 17) on April 3, 2024, for AMA Oncotype Prostate Cancer Testing services. The work will be performed at Mdxhealth's facility in Irvine, California, with an ultimate completion date of April 2, 2025. This call order falls under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), a General Services Administration...
- This federal contract is for the provision of prostate cancer diagnostic testing services by Mdxhealth, Inc. to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The contract has a period of performance from October 1, 2020 to September 20, 2021, with a completion date of March 31, 2022. It is a firm fixed price delivery order issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $114,920.07, is for MDX health testing services to support the VA's healthcare delivery to veterans within VISN 19. This contract is part of a larger Medical Laboratory...
- This federal contract award to Mdxhealth, Inc. is for the provision of Oncotype DX Prostate Testing services to the Veterans Integrated Service Network (VISN) 17, which is part of the U.S. Department of Veterans Affairs (VA). The $319,293.00 Blanket Purchase Agreement (BPA) call contract is made under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and has a period of performance through April 30, 2026. Mdxhealth, a for-profit healthcare company...
- This federal contract was awarded by the Veterans Integrated Service Network 19 (VISN 19), a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company that specializes in molecular diagnostic services for cancer. The contract, valued at $90,117.06, is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for MDX Health Testing...
- This is a federal contract award by the Veterans Integrated Service Network 8 (VISN 8), which is part of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, valued at $144,666.36, is a Blanket Purchase Agreement (BPA) call for providing prostate cancer testing services to the VA. This contract is not set aside and is issued under the Medical Laboratory...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70066-36C25723A0027Blanket Purchase Agreement
- 36C25723A0027-36C25726N0254BPA Call
The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17) awarded Mdxhealth, Inc. a $15,964.65 firm fixed price contract call under an existing Blanket Purchase Agreement for Genomic Prostate Score (GPS) testing services. This contract call, with an ultimate completion date of June 4, 2027, represents a delivery order against Mdxhealth's $240,000 BPA for MDXHEALTH GPS services established on May 1, 2023 and extending through June 4, 2028. The contract is issued under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and carries no set-aside designation, allowing Mdxhealth to compete as a standard commercial vendor. Services will be performed at Mdxhealth's facility in Temple, Texas. Mdxhealth, Inc., a for-profit healthcare company headquartered in Irvine, California, specializes in molecular diagnostic services for cancer testing and analysis. The company maintains an active federal contracting presence with the VA across multiple Veterans Integrated Service Networks, providing advanced genomic and epigenetic testing services to support personalized diagnosis and treatment strategies for veterans. This contract supports the VA's delivery of specialized prostate cancer screening capabilities as part of the broader Veterans Health Administration mission to provide comprehensive healthcare services to the veteran population.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--674-23-3-035-0018 | NEW | CTX MDxHealth GPS | 36C25723Q0843 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 5/16/23, 12:58 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 2/12/26 |